|
Number
|
Age (years)
|
Gender (female/male)
|
---|
AD
|
72
|
66.67 (± 9.59)
|
39/33
|
bvFTD
|
146
|
61.68 (± 9.67)
|
53/93
|
CBS
|
26
|
65.96 (± 6.91)
|
15/11
|
lvPPA
|
30
|
67.33 (± 5.60)
|
13/17
|
MSA-C
|
21
|
63.05 (± 7.24)
|
11/10
|
MSA-P
|
60
|
63.29 (± 7.99)
|
38/22
|
nfvPPA
|
58
|
68.46 (± 8.32)
|
29/29
|
PD
|
203
|
64.08 (± 11.21)
|
135/68
|
PSP
|
154
|
69.03 (± 6.47)
|
82/72
|
svPPA
|
46
|
62.14 (± 8.31)
|
19/27
|
Healthy controls
|
124
|
63.71 (± 10.00)
|
60/64
|
- Data are reported as mean ± standard deviation
- Abbreviations: AD Alzheimer’s disease, bvFTD Behavioral variant frontotemporal dementia, CBS Corticobasal syndrome, lvPPA Logopenic variant primary progressive aphasia, MSA-C Multiple system atrophy (cerebellar dysfunction subtype), MSA-P Multiple system atrophy (parkinsonian subtype), nfvPPA Nonfluent variant primary progressive aphasia, PD Parkinson’s disease, PSP Progressive supranuclear palsy, svPPA Semantic variant primary progressive aphasia